Procter & Gamble Hygiene and Health Care (PGHH)₹7,138+1.35%Personal Care
In the Jun 2026 quarter (standalone), Procter & Gamble Hygiene and Health Care reported sales of ₹892 Cr, down 4.8% from Jun 2025, and net profit of ₹126 Cr, down 34.3% year on year. For the year to Mar 2026, sales were ₹4,298 Cr and net profit ₹856 Cr.
Company filings, standalone accounts; latest reported quarter Jun 2026
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,140 | 1,135 | 1,004 | 933 | 1,136 | 1,249 | 993 | 938 | 1,151 | 1,263 | 943 | 892 |
| Expenses | 857 | 827 | 747 | 816 | 848 | 881 | 785 | 674 | 869 | 863 | 726 | 724 |
| Operating Profit | 285 | 309 | 257 | 118 | 290 | 370 | 210 | 266 | 285 | 401 | 218 | 170 |
| OPM % | 25.0% | 27.0% | 26.0% | 13.0% | 26.0% | 30.0% | 21.0% | 28.0% | 25.0% | 32.0% | 23.0% | 19.0% |
| Other Income | 16.05 | 16.03 | 14.05 | 7.02 | 8.02 | 10.03 | 19.04 | 8.02 | 10.02 | 12.03 | 12.03 | 9.03 |
| Interest | 1.99 | 2.99 | 21.95 | 0.00 | 1.99 | 6.98 | 5.98 | 0.00 | 3.99 | 2.99 | 2.99 | 0.00 |
| Depreciation | 13.95 | 13.96 | 14.94 | 12.96 | 11.96 | 9.97 | 9.97 | 8.97 | 8.97 | 9.97 | 9.97 | 9.97 |
| Profit before tax | 284 | 309 | 234 | 112 | 285 | 365 | 213 | 265 | 282 | 402 | 218 | 170 |
| Tax % | 26.0% | 26.0% | 34.0% | 28.0% | 26.0% | 26.0% | 27.0% | 27.0% | 26.0% | 25.0% | 30.0% | 26.0% |
| Net Profit | 211 | 229 | 154 | 81.03 | 212 | 269 | 156 | 192 | 210 | 301 | 153 | 126 |
| EPS (Rs) | 65.18 | 70.83 | 47.72 | 25.06 | 65.58 | 83.07 | 48.26 | 59.38 | 64.95 | 93.26 | 47.38 | 39.05 |
| Jun 2016 | Jun 2017 | Jun 2018 | Jun 2019 | Jun 2020 | Jun 2021 | Jun 2022 | Jun 2023 | Jun 2024 | Mar 2025 9m | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 2,280 | 2,323 | 2,457 | 2,951 | 3,004 | 3,580 | 3,906 | 3,924 | 4,213 | 3,378 | 4,298 | 4,249 |
| Expenses | 1,674 | 1,653 | 1,841 | 2,339 | 2,406 | 2,697 | 3,078 | 3,059 | 3,242 | 2,513 | 3,133 | 3,181 |
| Operating Profit | 607 | 675 | 621 | 617 | 606 | 885 | 830 | 867 | 974 | 869 | 1,169 | 1,074 |
| OPM % | 27.0% | 29.0% | 25.0% | 21.0% | 20.0% | 25.0% | 21.0% | 22.0% | 23.0% | 26.0% | 27.0% | 25.3% |
| Other Income | 85.26 | 67.18 | 18.06 | 45.08 | 42.13 | 38.09 | 23.06 | 40.09 | 47.15 | 37.11 | 42.12 | 43.11 |
| Interest | 5.99 | 9.97 | 4.99 | 4.99 | 5.99 | 5.99 | 10.98 | 10.98 | 26.92 | 13.97 | 8.98 | 9.97 |
| Depreciation | 51.78 | 59.74 | 51.83 | 49.83 | 47.82 | 47.83 | 52.80 | 57.82 | 55.85 | 31.86 | 36.87 | 38.88 |
| Profit before tax | 637 | 673 | 582 | 608 | 595 | 871 | 791 | 840 | 940 | 863 | 1,168 | 1,073 |
| Tax % | 34.0% | 36.0% | 36.0% | 31.0% | 27.0% | 25.0% | 27.0% | 19.0% | 28.0% | 26.0% | 27.0% | — |
| Exceptional items | −1.99 | −5.98 | −3.99 | −5.99 | −1.99 | −0.99 | −0.99 | −0.99 | −3.99 | 0.00 | 0.00 | — |
| Net Profit | 422 | 433 | 375 | 419 | 433 | 652 | 576 | 678 | 675 | 637 | 856 | 790 |
| EPS (Rs) | 130.73 | 133.93 | 115.77 | 129.72 | 133.95 | 201.62 | 177.97 | 209.60 | 208.72 | 197.02 | 265.02 | 244.64 |
| Dividend payout % | 28.1% | 292.0% | 35.0% | 68.0% | 79.0% | 157.0% | 90.0% | 89.0% | 123.0% | 89.0% | 97.0% | — |
| Jun 2015 | Jun 2016 | Jun 2017 | Jun 2018 | Jun 2019 | Jun 2020 | Jun 2021 | Jun 2022 | Jun 2023 | Jun 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 31.89 | 31.91 | 31.94 | 31.94 | 31.90 | 31.94 | 31.91 | 31.93 | 31.90 | 31.93 | 31.91 | 31.93 |
| Reserves | 1,199 | 1,623 | 496 | 775 | 880 | 1,128 | 684 | 707 | 917 | 744 | 707 | 723 |
| Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 3.01 | 4.99 | 4.01 | 3.01 | 2.01 | 1.01 |
| Other Liabilities | 717 | 513 | 633 | 620 | 708 | 672 | 914 | 940 | 1,188 | 1,083 | 1,016 | 1,049 |
| Total Liabilities | 1,949 | 2,168 | 1,161 | 1,427 | 1,620 | 1,831 | 1,634 | 1,685 | 2,141 | 1,863 | 1,758 | 1,807 |
| Fixed Assets | 308 | 316 | 286 | 250 | 234 | 206 | 184 | 164 | 170 | 139 | 131 | 163 |
| CWIP | 38.82 | 34.88 | 40.85 | 20.91 | 14.94 | 21.90 | 37.86 | 43.83 | 22.92 | 27.89 | 40.87 | 20.92 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Assets | 1,602 | 1,816 | 835 | 1,157 | 1,371 | 1,604 | 1,412 | 1,478 | 1,949 | 1,696 | 1,587 | 1,622 |
| Inventories | 119 | 127 | 178 | 124 | 204 | 206 | 250 | 235 | 221 | 227 | 222 | 219 |
| Trade receivables | 114 | 150 | 133 | 148 | 181 | 166 | 142 | 192 | 216 | 241 | 304 | 243 |
| Cash & equivalents | 621 | 1,076 | 117 | 401 | 541 | 904 | 661 | 641 | 980 | 590 | 482 | 570 |
| Total Assets | 1,949 | 2,168 | 1,161 | 1,427 | 1,620 | 1,831 | 1,634 | 1,685 | 2,141 | 1,863 | 1,758 | 1,807 |
| Jun 2015 | Jun 2016 | Jun 2017 | Jun 2018 | Jun 2019 | Jun 2020 | Jun 2021 | Jun 2022 | Jun 2023 | Jun 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | 426 | 352 | 445 | 415 | 413 | 474 | 864 | 573 | 826 | 470 | 593 | 925 |
| Cash from investing activity | 28.07 | 222 | 149 | −19.03 | 34.09 | 75.14 | 7.01 | −27.05 | −10.03 | 1.01 | −34.06 | 11.02 |
| Cash from financing activity | −105 | −122 | −1,559 | −106 | −314 | −190 | −1,106 | −569 | −477 | −861 | −666 | −845 |
| Net cash flow | 350 | 453 | −966 | 291 | 134 | 359 | −237 | −23.05 | 340 | −391 | −107 | 91.15 |
| Capex | 78.24 | 52.49 | 44.02 | 38.00 | 16.05 | 50.86 | 31.53 | 49.67 | 44.28 | 44.55 | 54.87 | 49.39 |
| Free cash flow | 347 | 299 | 400 | 376 | 409 | 422 | 829 | 521 | 779 | 425 | 538 | 891 |
| CFO / OP % | 127.0% | 91.0% | 103.0% | 111.0% | 105.0% | 102.0% | 126.0% | 99.0% | 121.0% | 79.0% | 96.0% | 105.0% |
| Jun 2015 | Jun 2016 | Jun 2017 | Jun 2018 | Jun 2019 | Jun 2020 | Jun 2021 | Jun 2022 | Jun 2023 | Jun 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor days | 18 | 24 | 21 | 22 | 22 | 20 | 15 | 18 | 20 | 21 | 33 | 21 |
| Inventory days | 47 | 53 | 71 | 48 | 60 | 68 | 78 | 55 | 48 | 51 | 64 | 51 |
| Days payable | 148 | 134 | 145 | 156 | 162 | 175 | 237 | 183 | 213 | 193 | 235 | 197 |
| Cash conversion cycle | −83 | −57 | −53 | −87 | −79 | −87 | −144 | −110 | −145 | −121 | −138 | −126 |
| Working capital days | 3 | 7 | −16 | −24 | −13 | −22 | −40 | −35 | −54 | −33 | −32 | −32 |
| ROCE % | 46.0% | 45.0% | 64.0% | 89.0% | 73.0% | 58.0% | 94.0% | 110.0% | 101.0% | 112.0% | 104.0% | 157.0% |
For the Jun 2026 quarter, Procter & Gamble Hygiene and Health Care reported sales of ₹892 Cr, down 4.8% year on year and net profit of ₹126 Cr, down 34.3% year on year. The operating margin was 19.0%.
Procter & Gamble Hygiene and Health Care's sales for the year to Mar 2026 were ₹4,298 Cr; over the last twelve months they were ₹4,249 Cr.
Net profit for the year to Mar 2026 was ₹856 Cr, and ₹790 Cr over the last twelve months. Earnings per share over the same trailing period were ₹244.64.
Procter & Gamble Hygiene and Health Care reported borrowings of ₹1.01 Cr at Mar 2026, against cash and equivalents of ₹570 Cr.
Cash from operations was ₹925 Cr in the year to Mar 2026; after capital spending, free cash flow was ₹891 Cr.